ImmunityBio, Inc.
NASDAQ:IBRXBiotechnology
Healthcare
$6.57 +2.58%
+$0.18 today
- Market cap
- $6.99B
- Beta
- 0.10
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.83
52W Low $1.95High $12.43
Volume 11.10M
Average 16.40M
Price history
ImmunityBio, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+225.25%
Period high
$11.55
Period low
$1.98
Latest
$6.57
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 9, 2026 | Nov 9, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| 8-K | Oct 14, 2026 | Oct 14, 2026 | |
| 4 | Oct 6, 2026 | Oct 6, 2026 | |
| 4 | Oct 6, 2026 | Oct 6, 2026 | |
| SC 13D/A | Aug 6, 2026 | Aug 6, 2026 | |
| 8-K | Aug 4, 2026 | Aug 4, 2026 | |
| 10-Q | Aug 4, 2026 | Aug 4, 2026 | |
| 8-K | Jul 30, 2026 | Jul 30, 2026 | |
| 4 | Jul 6, 2026 | Jul 6, 2026 | |
| 4 | Jul 6, 2026 | Jul 6, 2026 | |
| 4 | Jul 1, 2026 | Jul 1, 2026 | |
| 4 | Jun 26, 2026 | Jun 26, 2026 | |
| 4 | Jun 10, 2026 | Jun 10, 2026 |
Competitors
Who does ImmunityBio, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about IBRX's filings, answered from its disclosures.
What is the latest IBRX filing?
The latest filing shown is 10-Q dated Nov 9, 2026.
How many recent filings does IBRX have?
Intrinsic Alpha currently shows 20 recent filings for IBRX.
Continue the stock analysis
Jump to another research area for this company.